We are comprised of a dedicated group of scientists focused on developing next-generation therapeutics to treat chronic diseases.
We use PASylation® a proprietary and powerful chemistry platform to design novel long-acting peptides with fine-tuned pharmacologic and pharmacokinetic properties to create promising therapeutics for multiple chronic diseases.
At Antlia Bioscience, we are driven to make a profound difference in the treatment of cardiovascular and pulmonary diseases. Our work is supported by world-class advisors and collaborators who are all aligned with our vision to bring life-changing therapies to the market.
Company Details
- Employees
- 4
- Founded
- 2021
- Address
- Encinitas, Ca 92024, Us
- Industry
- Biotechnology
- Website
- http://www.antliabio.com
- Keywords
- Canberra.
- HQ
- Encinitas, CA
Antlia Bioscience, Inc. Questions
Antlia Bioscience, Inc.'s website is http://www.antliabio.com
Antlia Bioscience, Inc.'s LinkedIn profile is https://www.linkedin.com/company/antlia-bioscience-inc
Antlia Bioscience, Inc. has
4 employees.
View email and phone details for 4
employees at Antlia Bioscience, Inc..
Antlia Bioscience, Inc.'s industry is
Biotechnology
Antlia Bioscience, Inc.'s top competitors are
Inflamma Therapeutics,
Antlia Displays,
Curie.bio,
Antlia,
Antlia,
Barthel Legal,
Myracle Therapeutics,
Avidity Biosciences, Inc.,
Newyorkbio,
Antlia Australia.
Antlia Bioscience, Inc.'s categories are Biotechnology
Antlia Bioscience, Inc.'s founding year is 2021
